Ignite Creation Date:
2025-12-24 @ 5:34 PM
Ignite Modification Date:
2026-02-20 @ 3:53 PM
Study NCT ID:
NCT04644068
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-08-24
First Post:
2020-10-26
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Study of AZD5305 as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Malignancies
Sponsor:
AstraZeneca
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Ovarian Cancer | View |
| None | Breast Cancer | View |
| None | Pancreatic Cancer | View |
| None | Prostate Cancer | View |
| None | Additional Indications Below for Module 4 and 5 | View |
| None | Non-small Cell Lung Cancer | View |
| None | Colorectal Cancer | View |
| None | Bladder Cancer | View |
| None | Gastric Cancer | View |
| None | Biliary Cancer | View |
| None | Cervical Cancer | View |
| None | Endometrial Cancer | View |
| None | Small Cell Lung Cancer Only in Module 5 | View |